The UK pharma industry association yesterday declared war on the latest NHS price control system – but the UK biotech industry counterpart seems far from convinced the move is helpful.
Astellas has failed to heed warnings about not following the UK pharma industry code, and has only narrowly avoided being expelled from industry membership.
The UK's world leading life sciences base could be under threat if a new Conservative government opts for immigration curbs over free trade post-Brexit, writes Andrew McConaghie